I am looking forward to working with an experienced team of radiation oncology experts who are dedicated to improving the quality of life for their patients,” said Dr. Hocko. “In addition, I hope to establish a larger role in the Riverside community as an educator on radiation cancer treatments available to patients.”
Dr. Hocko earned a Bachelor’s of Science degree in Microbiology at the University of Maryland in College Park, Maryland and a Doctorate of Medicine at the University of California, Irvine in Irvine, Calif. She completed her internship and residency at Loma Linda University Medical Center. Dr. Hocko specializes in the treatment of breast, gynecologic and lung malignancies.
“We are excited to welcome Dr. Hocko to our team,” said Leslie Botnick, M.D., Chief Medical Officer for Vantage Oncology. “With her personal and professional dedication to the field of radiation oncology, we are confident she will have an immediate impact on Vantage Oncology and Valley Radiotherapy Associates by helping us to advance our clinical quality efforts.”
ABOUT VANTAGE ONCOLOGY, INC.
Founded in October 2002, El Segundo, California-based Vantage Oncology, Inc. acquires, joint ventures, develops and operates state-of-the-art radiation oncology centers. Vantage Oncology was created in response to the growing need among cancer patients, hospitals and physicians for accessible and advanced radiation treatment therapies. Vantage Oncology is led by a seasoned management team, including Chief Executive Officer Michael Fiore, Medical Director Leslie Botnick, M.D., Chief Financial Officer Marshal Salomon and Chief Development Officer Mark Ahern. For more information about Vantage Oncology, visit www.vantageoncology.com.
About Valley Radiotherapy Associates Medical Group, Inc.
Valley Radiotherapy Associates Medical Group, Inc. (VRA) was founded by Leslie E. Botnick, M.D. and Christopher M. Rose, M.D. in June 1983 to deliver radiation oncology services. Today, El Segundo, Calif.-based VRA has 30 board-certified radiation oncologists and provides advanced radiation therapy services to communities at 17 hospitals and freestanding centers in Los Angeles, Orange, Riverside, Imperial Valley and San Bernardino Counties in California; Denver and Vail, Colorado; and Santa Fe, New Mexico. VRA has distinguished itself during the past 20 years as one of the premier radiation oncology groups in the nation with a proven record of excellence in clinical treatment, superiority in service delivery and technical acumen to develop new cancer treatment programs. For more information about VRA, visit www.valley-radiotherapy.com.
CONTACT:
Trace Longo
Longo Communications
(562)467-2020
|